Cambridge Health Alliance Chooses Abridge to Improve Equitable Care for Multilingual Patient Population

SAN FRANCISCO, CA, and CAMBRIDGE, MA—November 26, 2024—Abridge, the leader in generative AI for clinical documentation, has finalized an agreement with Cambridge Health Alliance (CHA), the only public academic health system in Massachusetts, with nearly 600 clinicians offering equitable care to over 140,000 patients in Boston’s metro-north region. 

CHA chose Abridge because of its industry-leading multilingual capabilities that empower its clinicians—from primary care to pulmonology, orthopedics, pediatrics, and other specialties—to better serve its diverse, often underserved community. 

Abridge’s speech recognition technology automatically detects specialty and language to generate an appropriate clinical note, with no requirement to select languages in advance of a conversation. Abridge implements a scientifically rigorous evaluation process to validate the 28 languages it officially supports, including the 16 most-spoken in the U.S. More languages will be validated through the evaluation process based on the needs of systems across the country. Nearly half (43%) of the population CHA serves speaks a language other than English as a primary language; languages spoken include Portuguese and Spanish—both languages at which Abridge excels. 

“We provide equitable care to an incredibly diverse group of patients,” said Dr. Hannah Galvin, Chief Medical Information Officer at CHA. “It's challenging to speak in one language and type in another. Clinicians can now truly focus on the patient—regardless of language—and know that Abridge will create an English note at the end of the encounter.” 

“As AI becomes ubiquitous in clinical settings, we must ensure that its benefits are spread equitably among clinician and patient populations, which is why I am so thrilled to have the opportunity to work with CHA,” said Dr. Shiv Rao, CEO and Founder of Abridge. “Abridge’s market-leading automatic speech recognition and note generation technology continues to set the standard across hundreds of languages, specialties, care settings, and workflows.” 

Abridge is rapidly becoming the platform of choice for enterprise-wide deployment at leading healthcare systems across the country, including Riverside Health, Reid Health, University of Vermont Health Network, CHRISTUS Health, UChicago Medicine, Sutter Health, Yale New Haven Health System, UCI Health, Emory Healthcare, The University of Kansas Health System, UPMC, and many more. Recently, Mayo Clinic, Epic, and Abridge partnered on a generative AI ambient documentation workflow for nurses. Abridge has also formed partnerships with Wolters Kluwer, OpenNotes, and other leading healthcare organizations to enrich the Abridge platform ecosystem. Earlier this year, Abridge announced a $150M Series C financing, which includes a strategic investment from NVIDIA.

About Abridge

Abridge was founded in 2018 to power deeper understanding in healthcare. The AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most—their patients. With support for 28+ languages and 50+ specialties, Abridge is able to support a wide range of clinician and patient encounters.

Abridge’s enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time with deep EMR integrations. Powered by Linked Evidence and their auditable AI, Abridge is the only company that maps AI-generated summaries to ground truth, helping providers quickly trust and verify the output. As pioneers in generative AI for healthcare, Abridge is setting the industry standards for the responsible deployment of AI across health systems.

Abridge was also recently recognized on the 2024 Forbes AI 50 list, alongside companies like OpenAI, Anthropic, Databricks, and others.

About Cambridge Health Alliance

Cambridge Health Alliance is an academic community health system committed to providing high-quality care in Cambridge, Somerville and Boston’s metro-north communities. CHA has expertise in primary care, specialty care and mental health/substance use services, as well as caring for diverse and complex populations. It includes two hospital campuses, a network of primary care and specialty practices and the Cambridge Public Health Dept. CHA patients have seamless access to advanced care through the system’s affiliation with Beth Israel Lahey Health. CHA is a Harvard Medical School teaching affiliate and is also affiliated with the Harvard T.H. Chan School of Public Health, Harvard School of Dental Medicine and Tufts University School of Medicine.